GlassScriptPhysician profile
Anindya Samanta
NPI 1104388826
$1,835.21
in general payments reported to CMS, 2019-2025
6 companies · $527 in 2025
The $527 reported for 2025 was more than what a typical Retina Specialist provider received nationally (typical 2025 total: $460).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $130 · 2021: $156 · 2022: $285 · 2023: $738 · 2025: $527.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $932 · Travel and Lodging: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $932.40 |
| Travel and Lodging | $332.66 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,307.16 | 2020-2025 | Unity, Hydrus Microstent, Clareon |
| Astellas Pharma US INC | $149.84 | 2025 | Izervay |
| Regeneron Healthcare Solutions, INC. | $130.16 | 2025 | Eylea Hd |
| Glaukos Corporation | $123.56 | 2023 | Iaccess Precision Blade |
| Genentech, INC. | $93.49 | 2025 | Vabysmo |
| Genentech USA, INC. | $31.00 | 2025 | Vabysmo |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anindya Samanta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.